176 related articles for article (PubMed ID: 29549189)
41. Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
Rotstein D; Solomon JM; Sormani MP; Montalban X; Ye XY; Dababneh D; Muccilli A; Shah P
Neurology; 2022 Jul; 99(2):e209-e220. PubMed ID: 35473761
[TBL] [Abstract][Full Text] [Related]
42. Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Bisecco A; Caiazzo G; d'Ambrosio A; Sacco R; Bonavita S; Docimo R; Cirillo M; Pagani E; Filippi M; Esposito F; Tedeschi G; Gallo A
Mult Scler; 2016 Nov; 22(13):1676-1684. PubMed ID: 26846989
[TBL] [Abstract][Full Text] [Related]
43. Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
Arnold DL; Calabresi PA; Kieseier BC; Sheikh SI; Deykin A; Zhu Y; Liu S; You X; Sperling B; Hung S
BMC Neurol; 2014 Dec; 14():240. PubMed ID: 25551571
[TBL] [Abstract][Full Text] [Related]
44. Sodium in the Relapsing-Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue Anisotropy.
Solanky BS; Prados F; Tur C; Yiannakas MC; Kanber B; Cawley N; Brownlee W; Ourselin S; Golay X; Ciccarelli O; Gandini Wheeler-Kingshott CAM
J Magn Reson Imaging; 2020 Nov; 52(5):1429-1438. PubMed ID: 32476227
[TBL] [Abstract][Full Text] [Related]
45. Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis.
Rotstein D; Solomon JM; Sormani MP; Montalban X; Ye XY; Dababneh D; Muccilli A; Saab G; Shah P
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36224046
[TBL] [Abstract][Full Text] [Related]
46. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
47. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
[TBL] [Abstract][Full Text] [Related]
48. Diffusion tensor imaging reveals greater microstructure damage in lesional tissue that shrinks into cerebrospinal fluid in multiple sclerosis.
Bergsland N; Dwyer MG; Jakimovski D; Weinstock-Guttman B; Zivadinov R
J Neuroimaging; 2021 Sep; 31(5):995-1002. PubMed ID: 34081373
[TBL] [Abstract][Full Text] [Related]
49. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum.
Yu CS; Zhu CZ; Li KC; Xuan Y; Qin W; Sun H; Chan P
Radiology; 2007 Jul; 244(1):249-56. PubMed ID: 17522347
[TBL] [Abstract][Full Text] [Related]
50. Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
Moroso A; Ruet A; Lamargue-Hamel D; Munsch F; Deloire M; Coupé P; Charré-Morin J; Saubusse A; Ouallet JC; Planche V; Tourdias T; Dousset V; Brochet B
PLoS One; 2017; 12(8):e0182479. PubMed ID: 28792528
[TBL] [Abstract][Full Text] [Related]
51. Neural correlates of fatigue in multiple sclerosis: a combined neurophysiological and neuroimaging approach (R1).
Russo M; Calamuneri A; Cacciola A; Bonanno L; Naro A; Dattola V; Sessa E; Buccafusca M; Milardi D; Bramanti P; Calabrò RS; Quartarone A
Arch Ital Biol; 2017 Sep; 155(3):142-151. PubMed ID: 29220866
[TBL] [Abstract][Full Text] [Related]
52. No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study.
Neeb L; Bastian K; Villringer K; Gits HC; Israel H; Reuter U; Fiebach JB
Headache; 2015 Feb; 55(2):241-51. PubMed ID: 25644380
[TBL] [Abstract][Full Text] [Related]
53. Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis.
Marastoni D; Turano E; Tamanti A; Colato E; Pisani AI; Scartezzini A; Carotenuto S; Mazziotti V; Camera V; Anni D; Ziccardi S; Guandalini M; Pizzini FB; Virla F; Mariotti R; Magliozzi R; Bonetti B; Steinman L; Calabrese M
Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200265. PubMed ID: 38917380
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
[TBL] [Abstract][Full Text] [Related]
55. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
[TBL] [Abstract][Full Text] [Related]
56. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
[TBL] [Abstract][Full Text] [Related]
57. Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
Giorgio A; Stromillo ML; Bartolozzi ML; Rossi F; Battaglini M; De Leucio A; Guidi L; Maritato P; Portaccio E; Sormani MP; Amato MP; De Stefano N
Mult Scler; 2014 Feb; 20(2):214-9. PubMed ID: 23877971
[TBL] [Abstract][Full Text] [Related]
58. Diffusion tensor imaging study of pediatric patients with congenital hydrocephalus: 1-year postsurgical outcomes.
Mangano FT; Altaye M; McKinstry RC; Shimony JS; Powell SK; Phillips JM; Barnard H; Limbrick DD; Holland SK; Jones BV; Dodd J; Simpson S; Mercer D; Rajagopal A; Bidwell S; Yuan W
J Neurosurg Pediatr; 2016 Sep; 18(3):306-19. PubMed ID: 27203134
[TBL] [Abstract][Full Text] [Related]
59. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
[TBL] [Abstract][Full Text] [Related]
60. Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study.
Kern KC; Sarcona J; Montag M; Giesser BS; Sicotte NL
Neuroimage; 2011 Apr; 55(3):1169-77. PubMed ID: 21056674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
